Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
18.58
-0.38 (-2.00%)
At close: Dec 30, 2025, 4:00 PM EST
18.36
-0.22 (-1.18%)
Pre-market: Dec 31, 2025, 9:02 AM EST

Mesoblast Revenue

In the fiscal year ending June 30, 2025, Mesoblast had annual revenue of $17.20M with 191.39% growth. Mesoblast had revenue of $7.02M in the half year ending June 30, 2025, with 458.55% growth.

Revenue (ttm)
$17.20M
Revenue Growth
+191.39%
P/S Ratio
135.98
Revenue / Employee
$212,321
Employees
81
Market Cap
2.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202517.20M11.30M191.39%
Jun 30, 20245.90M-1.60M-21.32%
Jun 30, 20237.50M-2.71M-26.54%
Jun 30, 202210.21M2.78M37.36%
Jun 30, 20217.43M-24.72M-76.88%
Jun 30, 202032.16M15.43M92.30%
Jun 30, 201916.72M-619.00K-3.57%
Jun 30, 201817.34M14.93M618.95%
Jun 30, 20172.41M-40.14M-94.33%
Jun 30, 201642.55M22.79M115.31%
Jun 30, 201519.76M--
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings